To demonstrate the efficacy of primary percutaneous mechanical left ventricular unloading with the Impella CP® assist device in patients with acute decompensated heart failure (ADHF) and in-hospital worsening heart failure (WHF) vs. current standard of care with inotropes as first-line escalating therapy.
The purpose of this research study is to evaluate whether initial temporary circulatory support through the Impella CP® system in patients with acute decompensated heart failure (ADHF) and in-hospital worsening heart failure (WHF) in whom inotropes are deemed necessary, has the potential to reduce the heart failure related-clinical events compared to the current standard of care.